AutoGrow 3.0: an improved algorithm for chemically tractable, semi-automated protein inhibitor design.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3842281)

Published in J Mol Graph Model on May 23, 2013

Authors

Jacob D Durrant1, Steffen Lindert, J Andrew McCammon

Author Affiliations

1: Department of Chemistry & Biochemistry, University of California San Diego, La Jolla, CA 92093, USA. jdurrant@ucsd.edu

Articles cited by this

The Protein Data Bank. Nucleic Acids Res (2000) 187.10

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev (2001) 36.00

AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem (2010) 25.20

ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model (2005) 16.75

PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res (2004) 11.53

Open Babel: An open chemical toolbox. J Cheminform (2011) 11.12

BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res (2006) 10.36

Python: a programming language for software integration and development. J Mol Graph Model (1999) 9.04

PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res (2007) 7.07

Benchmarking sets for molecular docking. J Med Chem (2006) 5.57

Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate. J Biol Chem (1982) 3.84

An RNA ligase essential for RNA editing and survival of the bloodstream form of Trypanosoma brucei. Science (2001) 3.52

A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem (1999) 3.09

Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol Cell (2000) 3.01

Estimates of the ab initio limit for pi-pi interactions: the benzene dimer. J Am Chem Soc (2002) 2.53

Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov (2005) 1.83

Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei. Proc Natl Acad Sci U S A (2008) 1.73

High resolution crystal structure of a key editosome enzyme from Trypanosoma brucei: RNA editing ligase 1. J Mol Biol (2004) 1.67

The computer program LUDI: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des (1992) 1.66

NNScore: a neural-network-based scoring function for the characterization of protein-ligand complexes. J Chem Inf Model (2010) 1.21

Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1. PLoS Negl Trop Dis (2010) 1.20

A multidimensional strategy to detect polypharmacological targets in the absence of structural and sequence homology. PLoS Comput Biol (2010) 1.19

NNScore 2.0: a neural-network receptor-ligand scoring function. J Chem Inf Model (2011) 1.12

SPROUT: a program for structure generation. J Comput Aided Mol Des (1993) 1.12

Computer design of bioactive molecules: a method for receptor-based de novo ligand design. Proteins (1991) 1.10

Successful applications of computer aided drug discovery: moving drugs from concept to the clinic. Curr Top Med Chem (2010) 1.03

Farnesyl diphosphate synthase inhibitors from in silico screening. Chem Biol Drug Des (2013) 1.02

AutoGrow: a novel algorithm for protein inhibitor design. Chem Biol Drug Des (2009) 1.01

Functional and structural insights revealed by molecular dynamics simulations of an essential RNA editing ligase in Trypanosoma brucei. PLoS Negl Trop Dis (2007) 0.99

GroupBuild: a fragment-based method for de novo drug design. J Med Chem (1993) 0.95

Antimicrobial dihydrofolate reductase inhibitors--achievements and future options: review. J Chemother (2004) 0.93

PRO-LIGAND: an approach to de novo molecular design. 3. A genetic algorithm for structure refinement. J Comput Aided Mol Des (1995) 0.86

PRO-LIGAND: an approach to de novo molecular design. 1. Application to the design of organic molecules. J Comput Aided Mol Des (1995) 0.85

Potential drug-like inhibitors of Group 1 influenza neuraminidase identified through computer-aided drug design. Comput Biol Chem (2010) 0.84

A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer. Br J Clin Pharmacol (1999) 0.84

AutoClickChem: click chemistry in silico. PLoS Comput Biol (2012) 0.81

Three new powerful oseltamivir derivatives for inhibiting the neuraminidase of influenza virus. Biochem Biophys Res Commun (2010) 0.80

Concepts and applications of "natural computing" techniques in de novo drug and peptide design. Curr Pharm Des (2010) 0.78

Towards the development of novel Trypanosoma brucei RNA editing ligase 1 inhibitors. BMC Pharmacol (2011) 0.78

LigMerge: a fast algorithm to generate models of novel potential ligands from sets of known binders. Chem Biol Drug Des (2012) 0.77

Articles by these authors

PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res (2004) 11.53

Molecular dynamics simulations of biomolecules. Nat Struct Biol (2002) 7.68

Finite element solution of the steady-state Smoluchowski equation for rate constant calculations. Biophys J (2004) 6.67

Accelerated molecular dynamics: a promising and efficient simulation method for biomolecules. J Chem Phys (2004) 5.00

Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics (2006) 4.44

Molecular dynamics: survey of methods for simulating the activity of proteins. Chem Rev (2006) 3.18

Revisiting free energy calculations: a theoretical connection to MM/PBSA and direct calculation of the association free energy. Biophys J (2004) 2.69

Computational drug design accommodating receptor flexibility: the relaxed complex scheme. J Am Chem Soc (2002) 2.58

Constant pH molecular dynamics in generalized Born implicit solvent. J Comput Chem (2004) 2.43

HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs. Protein Sci (2004) 2.34

An improved relaxed complex scheme for receptor flexibility in computer-aided drug design. J Comput Aided Mol Des (2008) 2.16

Order N algorithm for computation of electrostatic interactions in biomolecular systems. Proc Natl Acad Sci U S A (2006) 2.15

Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase. J Med Chem (2008) 2.14

Generalized Born model with a simple, robust molecular volume correction. J Chem Theory Comput (2007) 2.10

Discovery of a novel binding trench in HIV integrase. J Med Chem (2004) 2.09

A novel switch region regulates H-ras membrane orientation and signal output. EMBO J (2008) 2.06

Standard free energy of releasing a localized water molecule from the binding pockets of proteins: double-decoupling method. J Am Chem Soc (2004) 2.00

Sampling of slow diffusive conformational transitions with accelerated molecular dynamics. J Chem Phys (2007) 1.93

Molecular dynamics simulations and drug discovery. BMC Biol (2011) 1.91

Structure and dynamics of the full-length lipid-modified H-Ras protein in a 1,2-dimyristoylglycero-3-phosphocholine bilayer. J Med Chem (2007) 1.84

Agonist-mediated conformational changes in acetylcholine-binding protein revealed by simulation and intrinsic tryptophan fluorescence. J Biol Chem (2004) 1.81

The relaxed complex method: Accommodating receptor flexibility for drug design with an improved scoring scheme. Biopolymers (2003) 1.80

POVME: an algorithm for measuring binding-pocket volumes. J Mol Graph Model (2010) 1.75

Mapping the nucleotide and isoform-dependent structural and dynamical features of Ras proteins. Structure (2008) 1.75

Application of the level-set method to the implicit solvation of nonpolar molecules. J Chem Phys (2007) 1.73

Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei. Proc Natl Acad Sci U S A (2008) 1.73

Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble. Chem Biol Drug Des (2008) 1.69

Antibacterial drug leads targeting isoprenoid biosynthesis. Proc Natl Acad Sci U S A (2012) 1.69

Ras conformational switching: simulating nucleotide-dependent conformational transitions with accelerated molecular dynamics. PLoS Comput Biol (2009) 1.67

A gating mechanism proposed from a simulation of a human alpha7 nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A (2005) 1.66

Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design. J Am Chem Soc (2007) 1.65

Routine Access to Millisecond Time Scale Events with Accelerated Molecular Dynamics. J Chem Theory Comput (2012) 1.65

Targeted molecular dynamics study of C-loop closure and channel gating in nicotinic receptors. PLoS Comput Biol (2006) 1.65

Channel opening motion of alpha7 nicotinic acetylcholine receptor as suggested by normal mode analysis. J Mol Biol (2005) 1.64

Feature-preserving adaptive mesh generation for molecular shape modeling and simulation. J Mol Graph Model (2008) 1.64

Water in cavity-ligand recognition. J Am Chem Soc (2010) 1.63

Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: an ab initio QM/MM study. J Am Chem Soc (2002) 1.63

Exploring global motions and correlations in the ribosome. Biophys J (2005) 1.62

Toward a unified representation of protein structural dynamics in solution. J Am Chem Soc (2009) 1.55

Replica-Exchange Accelerated Molecular Dynamics (REXAMD) Applied to Thermodynamic Integration. J Chem Theory Comput (2008) 1.52

How does the cAMP-dependent protein kinase catalyze the phosphorylation reaction: an ab initio QM/MM study. J Am Chem Soc (2005) 1.51

Control of cation permeation through the nicotinic receptor channel. PLoS Comput Biol (2008) 1.51

Electrostatic free energy and its variations in implicit solvent models. J Phys Chem B (2008) 1.45

How Can Hydrophobic Association Be Enthalpy Driven? J Chem Theory Comput (2010) 1.44

Implementation of Accelerated Molecular Dynamics in NAMD. Comput Sci Discov (2011) 1.44

Electrodiffusion: a continuum modeling framework for biomolecular systems with realistic spatiotemporal resolution. J Chem Phys (2007) 1.43

The physical basis of microtubule structure and stability. Protein Sci (2003) 1.43

Gated binding of ligands to HIV-1 protease: Brownian dynamics simulations in a coarse-grained model. Biophys J (2006) 1.42

Activation and dynamic network of the M2 muscarinic receptor. Proc Natl Acad Sci U S A (2013) 1.41

Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations. J Am Chem Soc (2009) 1.40

Large conformational changes in proteins: signaling and other functions. Curr Opin Struct Biol (2010) 1.38

Increased membrane affinity of the C1 domain of protein kinase Cdelta compensates for the lack of involvement of its C2 domain in membrane recruitment. J Biol Chem (2005) 1.37

The influence of macromolecular crowding on HIV-1 protease internal dynamics. J Am Chem Soc (2006) 1.37

Proliferating cell nuclear antigen loaded onto double-stranded DNA: dynamics, minor groove interactions and functional implications. Nucleic Acids Res (2006) 1.37

Tetrameric mouse acetylcholinesterase: continuum diffusion rate calculations by solving the steady-state Smoluchowski equation using finite element methods. Biophys J (2004) 1.35

Studying functional dynamics in bio-molecules using accelerated molecular dynamics. Phys Chem Chem Phys (2011) 1.35

Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog (2010) 1.34

Allosteric networks in thrombin distinguish procoagulant vs. anticoagulant activities. Proc Natl Acad Sci U S A (2012) 1.33

Computation of electrostatic forces between solvated molecules determined by the Poisson-Boltzmann equation using a boundary element method. J Chem Phys (2005) 1.31

Limitations of atom-centered dielectric functions in implicit solvent models. J Phys Chem B (2005) 1.31

Potent, selective pyrone-based inhibitors of stromelysin-1. J Am Chem Soc (2005) 1.28

Molecular dynamics of acetylcholinesterase. Acc Chem Res (2002) 1.28

Nanosecond-timescale conformational dynamics of the human alpha7 nicotinic acetylcholine receptor. Biophys J (2007) 1.28

Ribosome motions modulate electrostatic properties. Biopolymers (2004) 1.27

Distinct glycan topology for avian and human sialopentasaccharide receptor analogues upon binding different hemagglutinins: a molecular dynamics perspective. J Mol Biol (2009) 1.27

Cryo-electron microscopy structure of adenovirus type 2 temperature-sensitive mutant 1 reveals insight into the cell entry defect. J Virol (2009) 1.27

Modelling cardiac calcium sparks in a three-dimensional reconstruction of a calcium release unit. J Physiol (2012) 1.26

Multiple pathways guide oxygen diffusion into flavoenzyme active sites. Proc Natl Acad Sci U S A (2009) 1.25

Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach. Chem Biol Drug Des (2010) 1.24

Coupling the Level-Set Method with Molecular Mechanics for Variational Implicit Solvation of Nonpolar Molecules. J Chem Theory Comput (2009) 1.23

Numerical analysis of Ca2+ signaling in rat ventricular myocytes with realistic transverse-axial tubular geometry and inhibited sarcoplasmic reticulum. PLoS Comput Biol (2010) 1.23

Fast peptidyl cis-trans isomerization within the flexible Gly-rich flaps of HIV-1 protease. J Am Chem Soc (2005) 1.23

Finite element simulations of acetylcholine diffusion in neuromuscular junctions. Biophys J (2003) 1.23

Interfaces and hydrophobic interactions in receptor-ligand systems: A level-set variational implicit solvent approach. J Chem Phys (2009) 1.22

Elucidating the inhibition mechanism of HIV-1 non-nucleoside reverse transcriptase inhibitors through multicopy molecular dynamics simulations. J Mol Biol (2009) 1.21

NNScore: a neural-network-based scoring function for the characterization of protein-ligand complexes. J Chem Inf Model (2010) 1.21

Calculating pKa values in enzyme active sites. Protein Sci (2003) 1.21

Novel allosteric sites on Ras for lead generation. PLoS One (2011) 1.20

Studying enzyme binding specificity in acetylcholinesterase using a combined molecular dynamics and multiple docking approach. J Am Chem Soc (2002) 1.20

Conformational selection in G-proteins: lessons from Ras and Rho. Biophys J (2010) 1.20

A multidimensional strategy to detect polypharmacological targets in the absence of structural and sequence homology. PLoS Comput Biol (2010) 1.19

Barriers to ion translocation in cationic and anionic receptors from the Cys-loop family. J Am Chem Soc (2007) 1.19

Phosphorylation effects on cis/trans isomerization and the backbone conformation of serine-proline motifs: accelerated molecular dynamics analysis. J Am Chem Soc (2005) 1.19

Finite element analysis of the time-dependent Smoluchowski equation for acetylcholinesterase reaction rate calculations. Biophys J (2007) 1.18

Electrostatic interaction between RNA and protein capsid in cowpea chlorotic mottle virus simulated by a coarse-grain RNA model and a Monte Carlo approach. Biopolymers (2004) 1.18

Enhanced conformational space sampling improves the prediction of chemical shifts in proteins. J Am Chem Soc (2010) 1.18

Mechanism of acetylcholinesterase inhibition by fasciculin: a 5-ns molecular dynamics simulation. J Am Chem Soc (2002) 1.17

Multivariate analysis of conserved sequence-structure relationships in kinesins: coupling of the active site and a tubulin-binding sub-domain. J Mol Biol (2007) 1.17

Ligand-induced conformational change in the alpha7 nicotinic receptor ligand binding domain. Biophys J (2005) 1.17

Asymmetric structural motions of the homomeric alpha7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation. Biophys J (2003) 1.17

Flap opening dynamics in HIV-1 protease explored with a coarse-grained model. J Struct Biol (2006) 1.17

On the evaluation and optimization of protein X-ray structures for pKa calculations. Protein Sci (2003) 1.17

Acetylcholinesterase: enhanced fluctuations and alternative routes to the active site in the complex with fasciculin-2. J Am Chem Soc (2004) 1.16

Accessing a hidden conformation of the maltose binding protein using accelerated molecular dynamics. PLoS Comput Biol (2011) 1.16

H-ras protein in a bilayer: interaction and structure perturbation. J Am Chem Soc (2007) 1.16

Potentials of mean force for acetylcholine unbinding from the alpha7 nicotinic acetylcholine receptor ligand-binding domain. J Am Chem Soc (2006) 1.15

Towards an in vivo biologically inspired nanofactory. Nat Nanotechnol (2007) 1.15

Structural and dynamic properties of water around acetylcholinesterase. Protein Sci (2002) 1.15

Induced fit or conformational selection? The role of the semi-closed state in the maltose binding protein. Biochemistry (2011) 1.14